GR3006383T3 - - Google Patents

Info

Publication number
GR3006383T3
GR3006383T3 GR920402456T GR920402456T GR3006383T3 GR 3006383 T3 GR3006383 T3 GR 3006383T3 GR 920402456 T GR920402456 T GR 920402456T GR 920402456 T GR920402456 T GR 920402456T GR 3006383 T3 GR3006383 T3 GR 3006383T3
Authority
GR
Greece
Prior art keywords
aqueous
water
solutions
doxorubicin hcl
dihydroxybutane
Prior art date
Application number
GR920402456T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006383T3 publication Critical patent/GR3006383T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR920402456T 1987-07-16 1992-11-30 GR3006383T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7418987A 1987-07-16 1987-07-16

Publications (1)

Publication Number Publication Date
GR3006383T3 true GR3006383T3 (el) 1993-06-21

Family

ID=22118210

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402456T GR3006383T3 (el) 1987-07-16 1992-11-30

Country Status (11)

Country Link
EP (1) EP0299528B1 (el)
JP (1) JPS6438021A (el)
KR (1) KR920004096B1 (el)
AT (1) ATE82682T1 (el)
AU (1) AU615454B2 (el)
DE (1) DE3876160T2 (el)
DK (1) DK396188A (el)
ES (1) ES2052646T3 (el)
FI (1) FI883337A (el)
GR (1) GR3006383T3 (el)
PT (1) PT88015B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02200636A (ja) * 1988-12-05 1990-08-08 Bristol Myers Squibb Co ドキソルビシン非水溶液
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
RU2065307C1 (ru) * 1994-12-13 1996-08-20 Александр Васильевич Тихонов Способ лечения первичного рака печени и набор для лечения первичного рака печени
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5946961A (en) * 1998-05-01 1999-09-07 Buhrke Industries, Inc. Web bowing apparatus
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
WO2014019095A1 (de) * 2012-08-03 2014-02-06 Mestex Ag Resiniferatoxin-lösung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191847A (en) * 1978-10-20 1982-05-31 Lilly Co Eli Stabilized pharmaceutical solutions of erythromycin
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
EP0299528A1 (en) 1989-01-18
KR890001570A (ko) 1989-03-27
PT88015B (pt) 1995-03-01
EP0299528B1 (en) 1992-11-25
DE3876160D1 (de) 1993-01-07
PT88015A (pt) 1989-06-30
AU1905188A (en) 1989-01-19
DK396188D0 (da) 1988-07-15
JPH0559093B2 (el) 1993-08-30
DK396188A (da) 1989-01-17
JPS6438021A (en) 1989-02-08
KR920004096B1 (ko) 1992-05-25
FI883337A0 (fi) 1988-07-13
ATE82682T1 (de) 1992-12-15
ES2052646T3 (es) 1994-07-16
DE3876160T2 (de) 1993-04-01
FI883337A (fi) 1989-01-17
AU615454B2 (en) 1991-10-03

Similar Documents

Publication Publication Date Title
NO173365C (no) Fremgangsm}te for fremstilling av et i det vesentlige ikke-sviende, vandig, antiinflammatorisk steroidpreparat egnet for intranasal administerering
GR3006383T3 (el)
GR3004383T3 (el)
ES453970A1 (es) Un metodo para estabilizar una solucion de un compuesto de pirido (3,2-a)fenoxacina.
JPS51144734A (en) A remedy for hepatic failure
JPS51115775A (en) Semiconductor apparatus
GB1477624A (en) Amino acid parenteral solution containing reducing sugar
JPS51144733A (en) A remedy for hepatic failure
GR3007469T3 (el)
JPS51144735A (en) A remedy for hepatic failure
JPS51144732A (en) A remedy for hepatic failure
JPS5346916A (en) Preparation of hydroxyacetic acid
Bezotosnyi et al. CW buried-mesastripe GaInPAs/InP heterostructure lasers, operating at room temperature in the wavelength range 1. 24-1. 28 microns
JPS5268391A (en) Semiconductor laser
CA2048856A1 (en) 15-deoxyspergualin suppository
JPS537697A (en) 3-phenylhydantoic acid derivatives, their preparation and nonmedical fungicides containing the same as active constituents
GB2162746A (en) Antiacidotic medicinal agent